ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 249 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,688 | -22.9% | 12,605 | -11.5% | 0.16% | -20.8% |
| Q2 2023 | $340,928 | -7.2% | 14,235 | -27.1% | 0.20% | 0.0% |
| Q1 2023 | $367,366 | +20.4% | 19,520 | +1.8% | 0.20% | +27.0% |
| Q4 2022 | $305,234 | +28.8% | 19,173 | +32.3% | 0.16% | +69.1% |
| Q3 2022 | $237,000 | +17.9% | 14,493 | +1.5% | 0.09% | +25.3% |
| Q2 2022 | $201,000 | -48.7% | 14,280 | -11.7% | 0.08% | -57.1% |
| Q1 2022 | $392,000 | +4.0% | 16,172 | 0.0% | 0.18% | +23.2% |
| Q4 2021 | $377,000 | +35.1% | 16,172 | -3.7% | 0.14% | +15.4% |
| Q3 2021 | $279,000 | -37.6% | 16,785 | -8.4% | 0.12% | -33.2% |
| Q2 2021 | $447,000 | +44.2% | 18,330 | +52.7% | 0.18% | +40.5% |
| Q1 2021 | $310,000 | -50.3% | 12,004 | +2.8% | 0.13% | -49.4% |
| Q4 2020 | $624,000 | +18.6% | 11,675 | -8.4% | 0.26% | -6.2% |
| Q3 2020 | $526,000 | -7.1% | 12,748 | +9.2% | 0.28% | +3.0% |
| Q2 2020 | $566,000 | +0.9% | 11,674 | -12.1% | 0.27% | +16.0% |
| Q1 2020 | $561,000 | -8.9% | 13,276 | -7.8% | 0.23% | +128.7% |
| Q4 2019 | $616,000 | -40.1% | 14,396 | -49.6% | 0.10% | -51.2% |
| Q3 2019 | $1,028,000 | +15.2% | 28,563 | -14.4% | 0.21% | +10.1% |
| Q2 2019 | $892,000 | +76.6% | 33,367 | +110.1% | 0.19% | -23.0% |
| Q3 2016 | $505,000 | +12.2% | 15,878 | +14.4% | 0.24% | -26.9% |
| Q2 2016 | $450,000 | +118.4% | 13,877 | +88.6% | 0.33% | +17.6% |
| Q1 2016 | $206,000 | -26.2% | 7,357 | -5.8% | 0.28% | -62.9% |
| Q4 2015 | $279,000 | – | 7,814 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |